Follow the 지아이이노베이션 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지아이이노베이션 has published 131 insider filings. Market capitalisation: €486.9bn. The latest transaction was disclosed on 6 July 2026 (Purchase). Among the most active insiders: 장명호. The full history is openly available.
131
Insider Decl.
n/a
Thresholds
€155,031
59 ops.
Buy Volume
n/a
31 ops.
Sell Volume
19Σ signal
Buys €155,031n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
지아이이노베이션 is a company in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.
